Sign up for our daily briefing
Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.
Stay on top of the latest market trends
Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.
Sports news worthy of your time
Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.
Tech news worthy of your time
Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.
Get the inside stories
Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Want a daily digest of the top Denver news?
Get a daily digest of the most important stories affecting your hometown with Axios Denver
Want a daily digest of the top Des Moines news?
Get a daily digest of the most important stories affecting your hometown with Axios Des Moines
Want a daily digest of the top Twin Cities news?
Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities
Want a daily digest of the top Tampa Bay news?
Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay
Want a daily digest of the top Charlotte news?
Get a daily digest of the most important stories affecting your hometown with Axios Charlotte
Photo by Justin Sullivan/Getty Images
Drug distributors McKesson Corp., Cardinal Health Inc., AmerisourceBergen Corp. and Teva Pharmaceutical Industries, an Israeli-based manufacturer of generic drugs, reached a $260 million settlement on Monday to avoid the first federal opioid trial that was set to begin in Cleveland, the Wall Street Journal reports.
Why it matters: People familiar with the discussions told the New York Times that a broader settlement to resolve thousands of cases brought by local governments and states could be announced later in the day.
The settlement: McKesson, Cardinal Health and AmerisourceBergen, agreed to pay Ohio’s Cuyahoga and Summit counties $215 million.
- Teva will pay the counties $20 million over the next two years and donate $25 million worth of addiction-treatment drugs.
- The case's fifth defendant, Walgreens Boots Alliance, was not a part of the settlement, and U.S. District Judge Dan Polster postponed its trial.
Context: Almost every state and thousands of local governments have sued pharmaceutical companies for damages caused by the opioid crisis. In total, more than 2,300 opioid lawsuits have been brought in federal court by plaintiffs ranging from local municipalities to Native American tribes.
- The cases were consolidated before judge Polster in Cleveland, and the cases of Cuyahoga and Summit counties were selected to go to trial first.
By the numbers: The WSJ reports that overdoses of legal and illegal opioids have killed at least 400,000 people since 1999.
- Collectively, McKesson, Cardinal and AmerisourceBergen controlled 95% of the U.S. drug distribution market in 2018 and were among the largest corporations in the country.
- A coalition of state attorneys general has pushed for a settlement with five drug companies that could be worth as much as $48 billion.
Walgreens was included in the trial for its role as a drug distributor to its own stores, and Teva was included because it produces generic opioid painkillers.
Go deeper: